Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
GSK US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
GSK US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
GSK plc Sponsored ADR
(GSK US)
$50.45
+0.26
0.52%
Ext:
$51.79
+1.34
2.65%
(Market Closed · 01:00:04 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
GSK plc Sponsored ADR
(GSK US)
$50.45
+0.26
0.52%
Ext:
$51.79
+1.34
2.65%
(Market Closed · 01:00:04 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(6.4K)
Expand
6-K
BEXSERO BOOSTER RECEIVES POSITIVE CHMP OPINION
13 Nov
6-K
DIRECTOR/PDMR SHAREHOLDING
12 Nov
6-K
GSK PUBLISHES PROVISIONAL DIVIDEND DATES
6 Nov
6-K
TOTAL VOTING RIGHTS
2 Nov
6-K
3RD QUARTER RESULTS
28 Oct
6-K
RIS-REZ POSITIVE PH 3 OSTEOSARCOMA DATA IN CHINA
26 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
26 Oct
6-K
JEMPERLI DATA SHOW 76% COMPLETE RESPONSE RATE
26 Oct
6-K
POSITIVE MO-REZ PHASE IB DATA IN OVARIAN CANCER
26 Oct
6-K
US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B
21 Oct
6-K
JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER
19 Oct
6-K
RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER
19 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
15 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
14 Oct
S-8
Registration statement (employee benefit plan)
13 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
13 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
13 Oct
6-K
WENDY BECKER CBE - NEW DIRECTORSHIP
8 Oct
6-K
ADMISSION TO TRADING
6 Oct
6-K
TOTAL VOTING RIGHTS
1 Oct
Ownership Filings
(386)
Expand
13F-HR
Quarterly report (institutional investment manager holdings)
5 Nov
Form 144
Martinez Maria E
20 Aug
SC 13G/A
GSK plc
13 Aug
13F-HR
Quarterly report (institutional investment manager holdings)
13 Aug
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
17 Jun
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
17 Jun
13F-HR
Quarterly report (institutional investment manager holdings)
14 May
SC 13G
GSK plc
6 May
13F-HR
Quarterly report (institutional investment manager holdings)
12 Feb
Form 4
GSK plc
15 Dec 2025
SC 13D/A
CureVac N.V.
5 Dec 2025
SC 13D
CureVac N.V.
13 Aug 2025
11-K
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
18 Jun 2025
11-K
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE PLANS
18 Jun 2025
SC 13D/A
Spero Therapeutics, Inc.
28 Mar 2025
SC 13G/A
GSK plc
7 Mar 2025
SC 13D/A
23andMe Holding Co.
15 Nov 2024
SC 13G/A
GSK plc
12 Nov 2024
Form 4
GSK plc
1 Oct 2024
11-K
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
18 Jun 2024
Select Filings
Non-Ownership Filings
(6.4K)
Expand
6-K
BEXSERO BOOSTER RECEIVES POSITIVE CHMP OPINION
13 Nov
6-K
DIRECTOR/PDMR SHAREHOLDING
12 Nov
6-K
GSK PUBLISHES PROVISIONAL DIVIDEND DATES
6 Nov
6-K
TOTAL VOTING RIGHTS
2 Nov
6-K
3RD QUARTER RESULTS
28 Oct
6-K
RIS-REZ POSITIVE PH 3 OSTEOSARCOMA DATA IN CHINA
26 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
26 Oct
6-K
JEMPERLI DATA SHOW 76% COMPLETE RESPONSE RATE
26 Oct
6-K
POSITIVE MO-REZ PHASE IB DATA IN OVARIAN CANCER
26 Oct
6-K
US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B
21 Oct
6-K
JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER
19 Oct
6-K
RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER
19 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
15 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
14 Oct
S-8
Registration statement (employee benefit plan)
13 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
13 Oct
6-K
DIRECTOR/PDMR SHAREHOLDING
13 Oct
6-K
WENDY BECKER CBE - NEW DIRECTORSHIP
8 Oct
6-K
ADMISSION TO TRADING
6 Oct
6-K
TOTAL VOTING RIGHTS
1 Oct
Ownership Filings
(386)
Expand
13F-HR
Quarterly report (institutional investment manager holdings)
5 Nov
Form 144
Martinez Maria E
20 Aug
SC 13G/A
GSK plc
13 Aug
13F-HR
Quarterly report (institutional investment manager holdings)
13 Aug
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
17 Jun
11-K
Annual report (employee stock purchase/savings/profit sharing plans)
17 Jun
13F-HR
Quarterly report (institutional investment manager holdings)
14 May
SC 13G
GSK plc
6 May
13F-HR
Quarterly report (institutional investment manager holdings)
12 Feb
Form 4
GSK plc
15 Dec 2025
SC 13D/A
CureVac N.V.
5 Dec 2025
SC 13D
CureVac N.V.
13 Aug 2025
11-K
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
18 Jun 2025
11-K
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE PLANS
18 Jun 2025
SC 13D/A
Spero Therapeutics, Inc.
28 Mar 2025
SC 13G/A
GSK plc
7 Mar 2025
SC 13D/A
23andMe Holding Co.
15 Nov 2024
SC 13G/A
GSK plc
12 Nov 2024
Form 4
GSK plc
1 Oct 2024
11-K
ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE
18 Jun 2024
Ask in Filing
Ask in Filing
